Healthequity (HQY) Net Cash Flow (2013 - 2026)

Healthequity's Net Cash Flow history runs 14 years deep, the most recent figure standing at -$53.6 million for Q2 2026.

• On a quarterly basis, Net Cash Flow fell 564.99% year-over-year to -$53.6 million in Q2 2026; TTM through Apr 2026 was -$22.5 million, a 161.43% decrease from a year earlier, with the FY2026 full-year figure at $23.0 million, up 121.27% from the prior year.
• Net Cash Flow fell to -$53.6 million in Q2 2026 per HQY's latest filing, from $9.7 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $75.7 million in Q3 2024 and bottomed at -$423.7 million in Q1 2022.
• The 5-year median for Net Cash Flow is $7.2 million (2025), against an average of -$21.3 million.
• Across the five-year window, Net Cash Flow tumbled 1538.91% in 2022 and soared 313.73% in 2023, its largest moves.
• Year by year, Net Cash Flow stood at $33.3 million in 2022, then jumped by 31.24% to $43.7 million in 2023, then plunged by 110.82% to -$4.7 million in 2024, then jumped by 201.44% to $4.8 million in 2025, then tumbled by 1216.26% to -$53.6 million in 2026.
• Per Business Quant, the three latest HQY Net Cash Flow figures stand at -$53.6 million (Q2 2026), $9.7 million (Q1 2026), and $4.8 million (Q4 2025).